Trial intelligence / Profile preview

Oxytocin High-dose vs Low-dose for Labor Augmentation

NCT02487797Phase 4Completed

Sponsor
Northwestern University
Start
Sep 2015
Primary completion
Sep 2020
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of oxytocin in dystocia, sponsored by Northwestern University. Started Sep 2015; status: completed.

02

Drugs

oxytocin
03

Conditions

dystocia

Beyond the preview

Go deeper on NCT02487797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02487797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call